Cargando…

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes

Detalles Bibliográficos
Autores principales:	Kitamoto, Takumi, Takemoto, Minoru, Fujimoto, Masaki, Ishikawa, Takahiro, Onishi, Shunichiro, Okabe, Emiko, Ishibashi, Ryoichi, Kobayashi, Kazuki, Kawamura, Harukiyo, Yokote, Koutaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Online Letters: Observations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507596/ https://www.ncbi.nlm.nih.gov/pubmed/23173144 http://dx.doi.org/10.2337/dc12-1179

Ejemplares similares

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries
por: Sakamoto, Kenichi, et al.
Publicado: (2015)

A Case of Type 1 Diabetes With Nocturnal Hypoglycemia After Desensitization Therapy for Insulin Allergy
por: Kitamoto, Takumi, et al.
Publicado: (2013)

An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice
por: Koshizaka, Masaya, et al.
Publicado: (2012)

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial
por: Yokoh, Hidetaka, et al.
Publicado: (2015)

Werner syndrome: a model for sarcopenia due to accelerated aging
por: Yamaga, Masaya, et al.
Publicado: (2017)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation
por: Ishibashi, Ryoichi, et al.
Publicado: (2016)

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Helicobacter cinaedi infection in patients with diabetes: a case report
por: Ishibashi, Ryoichi, et al.
Publicado: (2015)

Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study)
por: Koshizaka, Masaya, et al.
Publicado: (2019)

Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Werner syndrome with refractory cystoid macular edema and immunohistochemical analysis of WRN proteins in human retinas
por: Oshitari, Toshiyuki, et al.
Publicado: (2014)

Favorable Effects of 24‐Week Whole-Body Vibration on Glycemic Control and Comprehensive Diabetes Therapy in Elderly Patients with Type 2 Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2021)

Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming
por: Shimamoto, Akira, et al.
Publicado: (2015)

Glycemic Control and Hypoglycemia: Is the Loser the Winner?: Response to Musen et al.
por: Perlmuter, Lawrence C., et al.
Publicado: (2009)

Glycemic Control and Hypoglycemia: Is the Loser the Winner?: Response to Perlmuter et al.
por: Musen, Gail, et al.
Publicado: (2009)

Improved Glycemic Control With the Multi-Receptor Tyrosine Kinase Inhibitor Pazopanib
por: Böhm, Steffen, et al.
Publicado: (2010)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015)

Time gap between the onset and diagnosis in Werner syndrome: a nationwide survey and the 2020 registry in Japan
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Optical coherence tomography findings in three patients with Werner syndrome
por: Nagai, Tatsuya, et al.
Publicado: (2022)

Characteristic Clinical Features of Werner Syndrome with a Novel Compound Heterozygous WRN Mutation c.1720+1G>A Plus c.3139-1G>C
por: Matsumoto, Namiko, et al.
Publicado: (2018)

Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020
por: Kato, Hisaya, et al.
Publicado: (2022)

Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus
por: Hiwasa, Takaki, et al.
Publicado: (2016)

Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture
por: Shimamoto, Akira, et al.
Publicado: (2014)

Calcification in Werner syndrome associated with lymphatic vessels aging
por: Ogata, Hideyuki, et al.
Publicado: (2021)

Targeted long-read sequencing identifies missing pathogenic variants in unsolved Werner syndrome cases
por: Miller, Danny E., et al.
Publicado: (2022)

Computer and Internet Use of Urban African Americans With Type 2 Diabetes in Relation to Glycemic Control, Emergency Department Use, Diabetes-Related Knowledge, and Health Literacy
por: Samal, Lipika, et al.
Publicado: (2010)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023)

Glucagon‐like peptide‐1 secretion by direct stimulation of L cells with luminal sugar vs non‐nutritive sweetener
por: Sakurai, Kenichi, et al.
Publicado: (2011)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
por: Ide, Kana, et al.
Publicado: (2018)

Senescence-associated inflammation and inhibition of adipogenesis in subcutaneous fat in Werner syndrome
por: Sawada, Daisuke, et al.
Publicado: (2023)

Gut Microbiota Contribution to Weight-Independent Glycemic Improvements after Gastric Bypass Surgery
por: Hankir, Mohammed K., et al.
Publicado: (2023)

A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
por: Miyabayashi, Makoto, et al.
Publicado: (2023)

Overproduction of Chromosomal ampC β-Lactamase Gene Maintains Resistance to Cefazolin in Escherichia coli Isolates
por: Kawamura, Masato, et al.
Publicado: (2022)

Effects of sitagliptin beyond glycemic control: focus on quality of life
por: Sakamoto, Yoshiko, et al.
Publicado: (2013)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020)

Factors predicting upstaging from clinical N0 to pN2a/N3a in breast cancer patients
por: Oda, Goshi, et al.
Publicado: (2022)

Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
por: Ishikawa, Ko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kh9lchcejktahs1fck8c5k2tph